129 related articles for article (PubMed ID: 38300595)
21. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
[TBL] [Abstract][Full Text] [Related]
22. Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028).
Li M; Chen J; Zhang B; Yu J; Wang N; Li D; Shao Y; Zhu D; Liang C; Ma Y; Ou Q; Hou X; Chen L
BMC Med; 2022 Nov; 20(1):398. PubMed ID: 36372873
[TBL] [Abstract][Full Text] [Related]
23. How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Mäusert J; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Lohmann DR; Jöckel KH
J Clin Oncol; 2016 Sep; 34(26):3183-8. PubMed ID: 27382102
[TBL] [Abstract][Full Text] [Related]
24. Potential of Aqueous Humor as a Surrogate Tumor Biopsy for Retinoblastoma.
Berry JL; Xu L; Murphree AL; Krishnan S; Stachelek K; Zolfaghari E; McGovern K; Lee TC; Carlsson A; Kuhn P; Kim JW; Cobrinik D; Hicks J
JAMA Ophthalmol; 2017 Nov; 135(11):1221-1230. PubMed ID: 29049475
[TBL] [Abstract][Full Text] [Related]
25. Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions.
Cobbs LV; Francis JH; Dunkel IJ; Gobin YP; Brodie SE; Abramson DH
Pediatr Blood Cancer; 2021 May; 68(5):e28845. PubMed ID: 33355996
[TBL] [Abstract][Full Text] [Related]
26. Prenatal versus Postnatal Screening for Familial Retinoblastoma.
Soliman SE; Dimaras H; Khetan V; Gardiner JA; Chan HS; Héon E; Gallie BL
Ophthalmology; 2016 Dec; 123(12):2610-2617. PubMed ID: 27712844
[TBL] [Abstract][Full Text] [Related]
27. RHEGMATOGENOUS RETINAL DETACHMENT AFTER INTRAARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: The 2016 Founders Award Lecture.
Shields CL; Say EAT; Pefkianaki M; Regillo CD; Caywood EH; Jabbour PM; Shields JA
Retina; 2017 Aug; 37(8):1441-1450. PubMed ID: 27787452
[TBL] [Abstract][Full Text] [Related]
28. Detectability of Plasma-Derived Circulating Tumor DNA Panel in Patients Undergoing Primary Treatment for Uveal Melanoma.
Francis JH; Barker CA; Brannon AR; Canestraro J; Robbins M; Swartzwelder CE; Levine S; Law C; Berger MF; Shoushtari A; Abramson DH
Invest Ophthalmol Vis Sci; 2022 Dec; 63(13):17. PubMed ID: 36525262
[TBL] [Abstract][Full Text] [Related]
29. Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer.
Kohli M; Tan W; Zheng T; Wang A; Montesinos C; Wong C; Du P; Jia S; Yadav S; Horvath LG; Mahon KL; Kwan EM; Fettke H; Yu J; Azad AA
EBioMedicine; 2020 Apr; 54():102728. PubMed ID: 32268276
[TBL] [Abstract][Full Text] [Related]
30. Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.
Akyüz C; Kıratlı H; Şen H; Aydın B; Tarlan B; Varan A
Ophthalmologica; 2015; 234(4):227-32. PubMed ID: 26368674
[TBL] [Abstract][Full Text] [Related]
31. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.
Tuncer S; Sencer S; Kebudi R; Tanyıldız B; Cebeci Z; Aydın K
Acta Ophthalmol; 2016 Nov; 94(7):e644-e651. PubMed ID: 27214798
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a prospective observational study.
Kim H; Kim YJ; Park D; Park WY; Choi DH; Park W; Cho WK; Kim N
Breast Cancer Res Treat; 2021 Aug; 189(1):167-175. PubMed ID: 34152505
[TBL] [Abstract][Full Text] [Related]
33. A novel de-novo RB1 mutation identified in a patient with bilateral retinoblastoma.
Fukushima H; Suzuki R; Hiraoka T; Suzuki S; Noguchi E; Takada H
Jpn J Clin Oncol; 2023 Aug; 53(9):863-865. PubMed ID: 37345682
[TBL] [Abstract][Full Text] [Related]
34. Intra-arterial Chemotherapy as Primary Treatment for Cavitary Retinoblastoma: Excellent Response in Eight Tumors.
Zheng Y; Froehler MT; Friedman DL; Daniels AB
Ophthalmol Retina; 2021 May; 5(5):479-485. PubMed ID: 32853834
[TBL] [Abstract][Full Text] [Related]
35. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
[TBL] [Abstract][Full Text] [Related]
36. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
37. Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC).
Ricciuti B; Jones G; Severgnini M; Alessi JV; Recondo G; Lawrence M; Forshew T; Lydon C; Nishino M; Cheng M; Awad M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33771889
[TBL] [Abstract][Full Text] [Related]
38. Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study.
Syeda MM; Wiggins JM; Corless BC; Long GV; Flaherty KT; Schadendorf D; Nathan PD; Robert C; Ribas A; Davies MA; Grob JJ; Gasal E; Squires M; Marker M; Garrett J; Brase JC; Polsky D
Lancet Oncol; 2021 Mar; 22(3):370-380. PubMed ID: 33587894
[TBL] [Abstract][Full Text] [Related]
39. Intra-arterial chemotherapy in refractory and advanced intraocular retinoblastoma.
Kumari N; Jain N; Saboo S; Parthasarathy R; Gupta V; Mahajan A; Das S
Indian J Ophthalmol; 2023 Feb; 71(2):436-443. PubMed ID: 36727336
[TBL] [Abstract][Full Text] [Related]
40. Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer.
Tarazona N; Gimeno-Valiente F; Gambardella V; Zuñiga S; Rentero-Garrido P; Huerta M; Roselló S; Martinez-Ciarpaglini C; Carbonell-Asins JA; Carrasco F; Ferrer-Martínez A; Bruixola G; Fleitas T; Martín J; Tébar-Martínez R; Moro D; Castillo J; Espí A; Roda D; Cervantes A
Ann Oncol; 2019 Nov; 30(11):1804-1812. PubMed ID: 31562764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
